News

1 2 3 4 5 ...nextlast

EU News - January 18

Today the H2020-MSCA-ITN-2018 call was successfully closed with 46 ITN proposals submitted of which 12 proposals as coordinator.  More info here.

Green Energy Park project Zellik launched!

On January 18, stakeholders gathered in the U-Residence at our campus in Etterbeek for the successful launch of the Green Energy Park Zellik project. This CO2 neutral smart grid will include solar and…

Interview with CEO of Collibra Felix Van de Maele

Since this week VUB spin-off Collibra has received investments of more than 100 million dollars from large American funders, such as Iconiq Capital. In an interview in De Tijd CEO Felix Van de Maele talks…

PharmaFluidics completed €7.3 million capital increase

VUB spin-off PharmaFluidics raises €7.3 million to expand commercialization of novel micro-chip device for biomarker, diagnostics and drug development applications. The company will focus on intensifying…

Flanders' FOOD

Flanders’ FOOD want to be the first address for supporting innovation along the whole agrifood chain and act as a lever for Flanders to become a European top region in agrifood. The Brussels Photonics…

VUB's immunotherapy cures melanoma patient

Melanoma patient Valérie has overcome skin cancer thanks to a new form of immunotherapy, developed at UZ Brussel by oncologist Bart Neyns. In immunotherapy, dendritic cells are removed from the patient's…

FWO call for Strategic Basic Research projects 2018

FWO launched the 2018 call for Strategic Basic Research projects. Two types of projects are possible: SBO -projects with a primary economical finality SBO-projects with a primary societal finalityMore…

Novo Nordisk makes an offer on Ablynx

Danish pharma multinational Novo Nordisk announced that it is willing to pay €2.6 billion for Ablynx, but the VUB biotech spin-off finds it too little. The Ablynx board concluded that the proposal undervalues…

Ablynx continues to rise

After the takeover bid on Ablynx, its share is picking up again and leaves the offer price of Novo Nordisk behind. Ablynx became the strongest climber on the market (+10,5%). Full article here. The biotech…

10 years of MOBI

When mobility research group MOBI was founded 10 years ago, it was ahead of its time. Today, sustainable mobility and electric cars are hot topics, both politically and economically. One of MOBI’s…
1 2 3 4 5 ...nextlast